Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness
Số trang: 14
Loại file: pdf
Dung lượng: 1.28 MB
Lượt xem: 9
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Treatment with tumor-Infiltrating Lymphocytes (TIL) is an innovative therapy for advanced melanoma with promising clinical phase I/II study results and likely beneficial cost-effectiveness. As a randomized controlled trial on the effectiveness of TIL therapy in advanced melanoma compared to ipilimumab is still ongoing, adoption of TIL therapy by the field is confronted with uncertainty.
Nội dung trích xuất từ tài liệu:
Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness
Nội dung trích xuất từ tài liệu:
Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Tumor-infiltrating lymphocytes Advanced melanoma Expert views Health technology assessmentGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 167 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 139 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 109 0 0 -
12 trang 87 0 0
-
19 trang 72 0 0
-
17 trang 60 0 0
-
9 trang 35 0 0
-
11 trang 35 0 0
-
12 trang 33 0 0